Cargando…
Combined Taurine, Epigallocatechin Gallate and Genistein Therapy Reduces HSC-T6 Cell Proliferation and Modulates the Expression of Fibrogenic Factors
Hepatic fibrogenesis involves the activation of hepatic stellate cells (HSCs), which synthesize excess extracellular matrix and contribute to the development of liver fibrosis. In a prior study we tested the effect of combined treatment with taurine, epigallocatechin gallate and genistein on the dev...
Autores principales: | Li, Yan, Luo, Ying, Zhang, Xuerong, Lin, Xing, He, Min, Liao, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821629/ https://www.ncbi.nlm.nih.gov/pubmed/24129183 http://dx.doi.org/10.3390/ijms141020543 |
Ejemplares similares
-
Correction: Yan, L., et al. Combined Taurine, Epigallocatechin Gallate and Genistein Therapy Reduces HSC-T6 Cell Proliferation and Modulates the Expression of Fibrogenic Factors. Int. J. Mol. Sci. 2013, 14, 20543–20554
por: Li, Yan, et al.
Publicado: (2021) -
Anti-fibrosis activity of combination therapy with epigallocatechin gallate, taurine and genistein by regulating glycolysis, gluconeogenesis, and ribosomal and lysosomal signaling pathways in HSC-T6 cells
por: Li, Yan, et al.
Publicado: (2018) -
Reducing the potential allergenicity of amandin through binding to (−)-epigallocatechin gallate
por: Luo, Xin, et al.
Publicado: (2022) -
Inhibition Mechanisms of (−)-Epigallocatechin-3-gallate
and Genistein on Amyloid-beta 42 Peptide of Alzheimer’s Disease
via Molecular Simulations
por: Fang, Mei, et al.
Publicado: (2022) -
Dietary Copper Reduces the Hepatotoxicity of (−)-Epigallocatechin-3-Gallate in Mice
por: Kaleri, Najeeb Ahmed, et al.
Publicado: (2017)